logo
Sign in

ZTS Stock Price, Chart, Stats & News

32.53B
Market cap
12.72x
Current P/E
11.34x
Forward P/E
2.65%
Dividend yield

ZTS chart

1M
3M
1Y
5Y
Loading chart...

Fundamentals

Gross margin
70.49%
Operating margin
38.00%
Pretax margin
35.49%
Net margin
28.23%
Effective tax rate
20.45%
ROA
17.28%
ROE
58.23%
D/E
2.85x
Interest coverage ratio
15.11x

ZTS valuation

P/E
12.72x
P/S
5.28x
P/B
14.91x
P/CF
17.10x
P/FCF
21.87x
P/OCF
17.10x
PEG
12.26x
EV multiple
10.46x

About

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms.

Similar securities

Based on sector and market capitalization

Report issue